One connector, four scholarly indexes, real DOIs and legal free PDFs. Works in Claude and ChatGPT.
Paste it into Claude or ChatGPT as a custom connector. 3-day free trial.
Natalie K. Wolf, Djem U. Kissiov, David H. Raulet
Great strides have been made in recent years towards understanding the roles of natural killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid cells that produce inflammatory cytokines and chemokines. By lysing transformed or infected cells, they limit tumour growth and viral infections. Whereas T cells recognize peptides presented by MHC molecules, NK cells display receptors that recognize stress-induced autologous proteins on cancer cells. At the same time, their functional activity is inhibited by MHC molecules displayed on such cells. The enormous potential of NK cells for immunotherapy for cancer is illustrated by their broad recognition of stressed cells regardless of neoantigen presentation, and enhanced activity against tumours that have lost expression of MHC class I owing to acquired resistance mechanisms. As a result, many efforts are under way to mobilize endogenous NK cells with therapeutics, or to provide populations of ex vivo-expanded NK cells as a cellular therapy, in some cases by equipping the NK cells with chimeric antigen receptors. Here we consider the key features that underlie why NK cells are emerging as important new additions to the cancer therapeutic arsenal. This Review explains how natural killer (NK) cells promote immunity to tumours. The authors cover the therapeutic approaches that are being developed to mobilize NK cells in patients with cancer, including NK cell activators, checkpoint blockade, cellular therapies, and bispecific and trispecific NK cell activating antibodies.
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2022). Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nature reviews. Immunology, 23(2), 90–105. https://doi.org/10.1038/s41577-022-00732-1
Wolf, Natalie K., et al. "Roles of natural killer cells in immunity to cancer, and applications to immunotherapy." Nature reviews. Immunology, vol. 23, no. 2, 2022, pp. 90–105, https://doi.org/10.1038/s41577-022-00732-1.
Wolf, Natalie K., Djem U. Kissiov, and David H. Raulet. "Roles of natural killer cells in immunity to cancer, and applications to immunotherapy." Nature reviews. Immunology 23, no. 2 (2022): 90–105. https://doi.org/10.1038/s41577-022-00732-1.
Wolf N. K., Kissiov D. U., Raulet D. H. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy // Nature reviews. Immunology. — 2022. — Vol. 23, № 2. — P. 90–105. — URL: https://doi.org/10.1038/s41577-022-00732-1
@article{wolf2022roles,
title = {{Roles of natural killer cells in immunity to cancer, and applications to immunotherapy}},
author = {Natalie K. Wolf and Djem U. Kissiov and David H. Raulet},
journal = {Nature reviews. Immunology},
year = {2022},
volume = {23},
number = {2},
pages = {90--105},
doi = {10.1038/s41577-022-00732-1},
url = {https://doi.org/10.1038/s41577-022-00732-1}
}TY - JOUR AU - Wolf, Natalie K. AU - Kissiov, Djem U. AU - Raulet, David H. TI - Roles of natural killer cells in immunity to cancer, and applications to immunotherapy JO - Nature reviews. Immunology VL - 23 IS - 2 SP - 90 EP - 105 PY - 2022 DA - 2022/05/30 DO - 10.1038/s41577-022-00732-1 UR - https://doi.org/10.1038/s41577-022-00732-1 ER -
Add Find Research to Claude or ChatGPT and ask in plain language. The assistant reads this record, finds the papers around it and cites only what it actually found:
Setup takes about a minute: add the connector, then start the free trial.
Record from OpenAlex; open-access location from Unpaywall and the indexes. Find Research links only to legal copies.